Expression of myelin and lymphocyte protein (MAL) in oral carcinogenesis

Med Mol Morphol. 2012 Dec;45(4):222-8. doi: 10.1007/s00795-011-0563-2. Epub 2012 Dec 7.

Abstract

In the pathological diagnosis of oral squamous cell carcinoma, we often confront the difficulty of determining whether it is invasive carcinoma or epithelial dysplasia. Recently, myelin and lymphocyte protein (MAL; T-cell differentiation-related gene) has been reported to be a candidate gene suppressed in esophageal carcinoma. When we performed cDNA microarray analysis, we found that gene expression of MAL was significantly downregulated in oral squamous cell carcinoma (OSCC). We evaluated the expression of the MAL gene by laser microdissection and real-time PCR methods and protein localization by immunohistochemistry. The gene expression of MAL was significantly decreased in OSCC compared with normal epithelium (P < 0.05). Furthermore, protein expression of MAL disappeared gradually in proportion to malignancy. The results suggest that MAL plays an important role during oral carcinogenesis and that the gene may have potential as a biomarker target for OSCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Epithelial Cells / metabolism
  • Epithelium / metabolism
  • Epithelium / pathology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mouth Neoplasms / genetics
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology
  • Myelin and Lymphocyte-Associated Proteolipid Proteins / genetics*
  • Myelin and Lymphocyte-Associated Proteolipid Proteins / metabolism*
  • Oligonucleotide Array Sequence Analysis / methods
  • Sulfites / chemistry

Substances

  • Biomarkers, Tumor
  • MAL protein, human
  • Myelin and Lymphocyte-Associated Proteolipid Proteins
  • Sulfites
  • hydrogen sulfite